Authors
Laura K Hilton, Christopher R Flowers, Jean L Koff
Published in
Blood cancer discovery. Pages OF1-OF5. Jun 24, 2026. Epub Jun 24, 2026.
Abstract
Although genomic classifiers have provided unprecedented insights into the biology of large B-cell lymphoma (LBCL), their ability to consistently predict outcomes across diverse patient populations and therapeutic contexts remains limited. Increasing evidence suggests that integrated models incorporating tumor genetics, transcriptional state, microenvironmental programs, and ancestry-informed biology will be required to realize the full promise of precision medicine in LBCL.
PMID:
42341193
Bibliographic data and abstract were imported from PubMed on 25 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0